From inflammation to cancer
- PMID: 27156054
- PMCID: PMC5323483
- DOI: 10.1007/s11845-016-1464-0
From inflammation to cancer
Abstract
Background: The participation of inflammation in the progression of cancer for many years have been the subject of research.
Methods: In the 19th century, there was evidence that an acute inflammation may inhibit the development of cancer. However, chronic inflammation affects the progression of the disease.
Results: Today, it is known that inflammation and cancer use similar mechanisms of development such as severe cell proliferation or angiogenesis. It has been shown that prolonged presence of inflammatory cells and factors in the tumor microenvironment can accelerate its growth and inhibit apoptosis of transformed cells.
Conclusion: In this article we present a brief history of the discovery mechanisms and potential links between acute and chronic inflammation and cancer.
Keywords: Acute inflammation; Adhesion molecules; Cancer; Chronic inflammation.
Conflict of interest statement
Conflict of interest
The authors have no conflicts of interest to disclose.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Similar articles
-
Angiogenesis links chronic inflammation with cancer.Methods Mol Biol. 2009;511:185-91. doi: 10.1007/978-1-59745-447-6_8. Methods Mol Biol. 2009. PMID: 19347298
-
The tumor microenvironment and its contribution to tumor evolution toward metastasis.Histochem Cell Biol. 2008 Dec;130(6):1091-103. doi: 10.1007/s00418-008-0530-8. Epub 2008 Nov 6. Histochem Cell Biol. 2008. PMID: 18987874 Review.
-
Crosstalk between cancer cells and endothelial cells: implications for tumor progression and intervention.Arch Pharm Res. 2018 Jul;41(7):711-724. doi: 10.1007/s12272-018-1051-1. Epub 2018 Jun 30. Arch Pharm Res. 2018. PMID: 29961196 Review.
-
Jekyll and Hyde: the role of the microenvironment on the progression of cancer.J Pathol. 2011 Jan;223(2):162-76. doi: 10.1002/path.2803. Epub 2010 Oct 29. J Pathol. 2011. PMID: 21125673 Review.
-
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.J Leukoc Biol. 2009 Nov;86(5):1065-73. doi: 10.1189/jlb.0609385. Epub 2009 Sep 9. J Leukoc Biol. 2009. PMID: 19741157 Review.
Cited by
-
The regulatory role of PDE4B in the progression of inflammatory function study.Front Pharmacol. 2022 Oct 6;13:982130. doi: 10.3389/fphar.2022.982130. eCollection 2022. Front Pharmacol. 2022. PMID: 36278172 Free PMC article. Review.
-
Neonatal administration of synthetic estrogen, diethylstilbestrol to mice up-regulates inflammatory Cxclchemokines located in the 5qE1 region in the vaginal epithelium.PLoS One. 2023 Mar 16;18(3):e0280421. doi: 10.1371/journal.pone.0280421. eCollection 2023. PLoS One. 2023. PMID: 36928065 Free PMC article.
-
Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: From the bench to bedside.Rev Endocr Metab Disord. 2024 Feb;25(1):5-17. doi: 10.1007/s11154-023-09846-w. Epub 2023 Oct 27. Rev Endocr Metab Disord. 2024. PMID: 37889392 Review.
-
Lunasin Attenuates Obesity-Associated Metastasis of 4T1 Breast Cancer Cell through Anti-Inflammatory Property.Int J Mol Sci. 2016 Dec 15;17(12):2109. doi: 10.3390/ijms17122109. Int J Mol Sci. 2016. PMID: 27983683 Free PMC article.
-
IDO1 and inflammatory neovascularization: bringing new blood to tumor-promoting inflammation.Front Oncol. 2023 Apr 27;13:1165298. doi: 10.3389/fonc.2023.1165298. eCollection 2023. Front Oncol. 2023. PMID: 37182174 Free PMC article. Review.
References
-
- Virchov R. Cellular pathology as based upon physiological and pathological histology. Philadelphia: J. B. Lippincott; 1863. - PubMed
-
- Trinchieri G. Inflammation in Cancer: a therapeutic target? Oncology (Williston Park) 2011;25:418–420. - PubMed
-
- Kołaczkowska E. Acute inflammation as a beneficial process—history and recent developments. Kosmos. 2007;56:27–38.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources